These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen. Jespersen J; Ingeberg S; Bach E Gynecol Obstet Invest; 1983; 15(3):153-62. PubMed ID: 6832651 [TBL] [Abstract][Full Text] [Related]
6. [A serial method for ovulation inhibition using ethinyl estradiol]. McBride WG Arzneimittelforschung; 1969 Aug; 19(8):1271-3. PubMed ID: 5820291 [No Abstract] [Full Text] [Related]
7. Effect of ethinyl oestradiol and megestrol acetate on carbohydrate metabolism in rabbits. Gaitonde BB; Kulkarni HJ Indian J Med Res; 1977 Aug; 66(2):223-35. PubMed ID: 924594 [No Abstract] [Full Text] [Related]
8. Individual levels of plasma histidine-rich glycoprotein (HRG) during the normal menstrual cycle and in women on oral contraceptives low in oestrogen. Jespersen J; Kluft C Scand J Clin Lab Invest; 1982 Nov; 42(7):563-6. PubMed ID: 6818678 [TBL] [Abstract][Full Text] [Related]
9. Metabolic effects of oral contraceptives containing 30 micrograms and 50 micrograms of oestrogen. Nash AL; Cornish EJ; Hain R Med J Aust; 1979 Sep; 2(6):277-81. PubMed ID: 230411 [TBL] [Abstract][Full Text] [Related]
11. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)]. Arnold M; Tóth I; Faredin I Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264 [No Abstract] [Full Text] [Related]
12. [Ovulation inhibition with low dosage gestagen components. Results of international clinical trial of Orlest]. Figoureux J; Onghena G; Schlikker E; Wattiez M; Schlösser W; Vercautere E; William P Munch Med Wochenschr; 1967 Dec; 109(48):2555-8. PubMed ID: 5631905 [No Abstract] [Full Text] [Related]
13. Oral contraceptives and blood-iron. Briggs M; Staniford M Lancet; 1969 Oct; 2(7623):742. PubMed ID: 4186184 [No Abstract] [Full Text] [Related]
14. Effect of 19-norsteroids on the motility of human fallopian tubes. Jakobovits A; Gecse A; Piukovich I; Szontágh F; Karády I Int J Fertil; 1970; 15(1):36-9. PubMed ID: 5416878 [No Abstract] [Full Text] [Related]
15. Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity. Howie PW; Mallinson AC; Prentice CR; Horne CH; McNicol GP Lancet; 1970 Dec; 2(7687):1329-32. PubMed ID: 4098907 [No Abstract] [Full Text] [Related]
16. Effect of different combinations of ethinyl estradiol & levonorgestrel on plasma lipids including high-density lipoprotein cholesterol. Mandal B; Maity CR Indian J Med Res; 1985 Apr; 81():382-6. PubMed ID: 3926642 [No Abstract] [Full Text] [Related]
17. BLOOD COAGULABILITY AND ORAL CONTRACEPTION. PILGERAM LO Br Med J; 1964 Apr; 1(5387):883-4. PubMed ID: 14102773 [No Abstract] [Full Text] [Related]
19. Immunological studies on human antithrombin 3. Influence of age, sex and use of oral contraceptives on serum concentration. Fagerhol MK; Abildgaard U Scand J Haematol; 1970; 7(1):10-7. PubMed ID: 4988538 [No Abstract] [Full Text] [Related]
20. [Contribution to the study of synthetic progestinics. Analysis of a 17-hydroxyprogesterone derivative combined with ethinyl-estradiol]. Peano M; Agnese M; Yammaki Y; Araujo Peano N; Groisman M; Canedo A; Correa A; Villano G; Cardoso A Minerva Ginecol; 1969 Dec; 21(24):1667-94. PubMed ID: 5374678 [No Abstract] [Full Text] [Related] [Next] [New Search]